Response to interleukin-12

pathway activity — cross-omics
GO:0070671Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to interleukin-12 pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RIPK2, TMEM144, and SH2D2A, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to interleukin-12 activity versus RIPK2 in BRCA (Pearson r = 0.15).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARIPK2 →+0.607+0.568.003.00334
GBMTMEM144 →+1.046+0.675.002.00134
CCRCCSH2D2A →+0.374+0.581.007<.00134
HNSCPRKCQ-AS1 →+0.877+0.571<.001.00333
PDACFCF1 →-0.265-0.603.005.00533
PDACSH3GLB2 →+0.395+0.753<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070671 vs RIPK2 — BRCA

Per-sample scatter of Response to interleukin-12 activity vs RIPK2 in BRCA.

Explore this scatter interactively →

Exploration